Related Experiment Video
Updated: Apr 4, 2026
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Published on: January 20, 2023
Lipid nanoparticle delivery of circle RNA vaccine induces potent immune responses
Ruohan Yang1, Lin Jia1, Jiuwei Cui2
1Cancer Center, the First Hospital of Jilin University, Changchun, 130021, China.
Abstract:
Circle RNA (circRNA) is a closed-loop nucleic acid resistant to exonuclease degradation. Their enhanced stability and potential for efficient protein expression through circRNA modification render them promising novel therapeutic agents for cancer treatment. In this study, we systematically investigated the antitumor and anti-inflammatory activities of circRNA vaccines in mice, as well as their effects on activating antigen-specific immune responses, through a meta-analysis. Subsequently, we further validated the immune-activating effects of circRNA using monocytes and T cells isolated from human peripheral blood mononuclear cells. We found that circRNA induces the activation and maturation of dendritic cells, as well as the responses of CD4 + and CD8 + T cells. These findings demonstrate the potential of circRNA to exert significant effects in therapeutic cancer vaccines.
Insights
Circular RNA (circRNA) vaccines show promise for cancer treatment by activating immune responses. These stable molecules effectively engage dendritic cells and T cells, demonstrating significant therapeutic potential in preclinical studies.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Circular RNA (circRNA) is a stable nucleic acid structure with potential for therapeutic applications.
- circRNA modification offers efficient protein expression, making it a candidate for novel cancer therapies.
Purpose of the Study:
- To systematically investigate the antitumor and anti-inflammatory activities of circRNA vaccines.
- To evaluate the effects of circRNA on antigen-specific immune responses.
- To validate the immune-activating properties of circRNA in human cells.
Main Methods:
- Meta-analysis of circRNA vaccine efficacy in mice.
- In vitro validation using human peripheral blood mononuclear cells, including monocytes and T cells.
Main Results:
- circRNA vaccines demonstrated antitumor and anti-inflammatory effects in mice.
- circRNA induced activation and maturation of dendritic cells.
- circRNA promoted responses in CD4+ and CD8+ T cells.
Conclusions:
- circRNA has significant potential as a therapeutic agent for cancer vaccines.
- circRNA effectively modulates both innate and adaptive immune responses.
- Further research into circRNA-based cancer immunotherapy is warranted.
Related Concept Videos
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...